Literature DB >> 9477820

Observation of Saccharomyces cerevisiae in blood of patient undergoing root canal treatment.

G J Debelian1, I Olsen, L Tronstad.   

Abstract

In this study, an unusual observation of Saccharomyces cerevisiae isolated from an infected root canal and from the blood of a patient undergoing endodontic therapy of a tooth with asymptomatic apical periodontitis is reported. Phenotypic (biochemical tests, antifungal susceptibility tests and SDS-PAGE of cellular proteins) and genetic (ribotyping) methods were used to characterize the strains. By using these methods it was found that the blood and root canal isolates were identical but differed from S. cerevisiae strains of other sources. It was therefore more than likely that the root canal was the source of the blood isolate and that it had been transferred unintentionally to the bloodstream during root canal treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9477820     DOI: 10.1046/j.1365-2591.1997.00101.x

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  3 in total

1.  Fatal Saccharomyces cerevisiae aortic graft infection.

Authors:  Davey Smith; David Metzgar; Christopher Wills; Joshua Fierer
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Prevalence of Candida albicans in primary endodontic infections associated with a higher frequency of apical periodontitis in type two diabetes mellitus patients.

Authors:  Rocio De la Torre-Luna; Rubén Abraham Domínguez-Pérez; Ana Laura Guillén-Nepita; José Luis Ayala-Herrera; Rita Elizabeth Martínez-Martínez; Ma Esther Romero-Ayala; Rosa Martha Pérez-Serrano; Ma Soledad Vázquez-Garcidueñas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-16       Impact factor: 3.267

3.  Pathogenic potential of Saccharomyces strains isolated from dietary supplements.

Authors:  Silvia Llopis; Carolina Hernández-Haro; Lucía Monteoliva; Amparo Querol; María Molina; María T Fernández-Espinar
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.